NBC Securities Inc. Has $401,000 Holdings in Ingevity Co. (NYSE:NGVT)

NBC Securities Inc. increased its position in shares of Ingevity Co. (NYSE:NGVT - Free Report) by 112,655.6% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,148 shares of the company's stock after purchasing an additional 10,139 shares during the quarter. NBC Securities Inc.'s holdings in Ingevity were worth $401,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. GAMMA Investing LLC lifted its position in Ingevity by 8,573.2% during the first quarter. GAMMA Investing LLC now owns 45,014 shares of the company's stock worth $17,820,000 after buying an additional 44,495 shares during the period. First Hawaiian Bank lifted its position in Ingevity by 19.6% during the first quarter. First Hawaiian Bank now owns 12,832 shares of the company's stock worth $508,000 after buying an additional 2,102 shares during the period. Wellington Management Group LLP lifted its position in Ingevity by 5.4% during the fourth quarter. Wellington Management Group LLP now owns 2,239,970 shares of the company's stock worth $91,279,000 after buying an additional 115,581 shares during the period. California State Teachers Retirement System lifted its position in Ingevity by 3.7% during the fourth quarter. California State Teachers Retirement System now owns 33,993 shares of the company's stock worth $1,385,000 after buying an additional 1,199 shares during the period. Finally, Wealth Enhancement Advisory Services LLC lifted its position in Ingevity by 28.8% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 7,674 shares of the company's stock worth $313,000 after buying an additional 1,717 shares during the period. 91.59% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

NGVT has been the topic of a number of research reports. Wells Fargo & Company raised their price objective on Ingevity from $32.00 to $38.00 and gave the stock an "equal weight" rating in a report on Wednesday, May 7th. Wall Street Zen upgraded Ingevity from a "buy" rating to a "strong-buy" rating in a report on Friday. Finally, BMO Capital Markets upgraded Ingevity from a "market perform" rating to an "outperform" rating and raised their price objective for the stock from $62.00 to $65.00 in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Ingevity presently has an average rating of "Buy" and an average target price of $52.75.

Ingevity Stock Performance

Shares of NGVT traded up $0.86 during mid-day trading on Friday, hitting $42.00. The stock had a trading volume of 187,351 shares, compared to its average volume of 278,616. The company has a market cap of $1.53 billion, a PE ratio of -3.55 and a beta of 1.39. Ingevity Co. has a fifty-two week low of $28.49 and a fifty-two week high of $51.67. The company has a quick ratio of 1.04, a current ratio of 1.87 and a debt-to-equity ratio of 6.86. The company's fifty day simple moving average is $36.98 and its two-hundred day simple moving average is $41.85.

Ingevity (NYSE:NGVT - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.99 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.74 by $0.25. The business had revenue of $284.00 million during the quarter, compared to analyst estimates of $299.13 million. Ingevity had a positive return on equity of 41.44% and a negative net margin of 30.60%. The business's revenue for the quarter was down 16.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.47 EPS. On average, equities analysts expect that Ingevity Co. will post 4.45 earnings per share for the current year.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.